Log in to your Inderes Free account to see all free content on this page.
Mentice
29.3 SEK +0.69%Be the first to follow this company
Mentice is a medical technology company. The company develops medical instruments for endovascular simulation and for training sessions in surgery. The programs are developed for educational use in hospitals and institutes. The largest operations are established in North America and Europe. In addition to the main business, the company also offers leasing, support, and technical service. The head office is located in Gothenburg.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
MNTC
Daily low / high price
28.8 / 29.5
SEK
Market cap
749.17M SEK
Turnover
892.35K SEK
Volume
31K
Financial calendar
Interim report
07.11.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Karin Howell-Bidermann | 34.0 % | 34.0 % |
Bure Equity AB | 14.7 % | 14.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Mentice publishes the company’s interim report for the period April - June 2024
Mentice to present the company's Q2-2024 Interim Report
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio